Slingshot members are tracking this event:
Aimmune (AIMT) Completes Enrollment for Phase 3 PALISADE Trial Evaluating AR101 in Peanut Allergies
Slingshot Insights Explained
Nov 28, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Enrollment, Phase 3, Palisade, Ar101, Peanut Allergies